AROPAX CR 12,5


Controlled release tablet
scheduling status
S5
registration number
A38/1.2/0612
What AROPAX CR 12,5 contains
Paroxetine hydrochloride hemihydrate.
other ingredients
Hypromellose, povidone, Lactose monohydrate, Magnesium stearate, Colloidal silicon dioxide, Glyceryl dibehenate, Methacrylic acid and ethyl acrylate copolymer dispersion, Talc, Triethyl citrate, Opadry yellow, 15B120039 (12,5 mg tablets), Opadry pink, Y-1-1262 (25 mg tablets) and the following colourants: Yellow ferric oxide (12,5 mg tablets) and Red ferric oxide (25 mg tablets).
Therapeutic classification
N06AB05.
© 2026 SAHPRA. ALL RIGHTS RESERVED